España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Jazz Pharmaceuticals
JAZZ
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$124.00
1.04
0.85%
Pre-Market: 7:09 AM EDT
Get Report
Comment
Jazz Pharmaceuticals (JAZZ) Forecast
News
Earnings
Jazz Pharmaceuticals (JAZZ) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
Jazz Pharmaceuticals Announces CEO Succession...
Benzinga Newsdesk
Thursday, December 12, 2024
Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Jazz Pha...
Benzinga Newsdesk
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Tuesday, December 10, 2024
RBC Capital Reiterates Outperform on Jazz Pha...
Benzinga Newsdesk
Monday, December 09, 2024
CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
Jelena Martinovic
Friday, December 06, 2024
Jazz Pharmaceuticals To Showcase New Real-Wor...
Benzinga Newsdesk
Thursday, December 05, 2024
Jazz Pharmaceuticals Announced That Zanidatam...
Benzinga Newsdesk
Tuesday, December 03, 2024
Jazz Pharmaceuticals To Present Advancements ...
Benzinga Newsdesk
Wednesday, November 27, 2024
Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
Vandana Singh
Friday, November 22, 2024
HC Wainwright & Co. Reiterates Buy on Jazz Ph...
Benzinga Newsdesk
Thursday, November 21, 2024
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Vandana Singh
Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk
Jazz Pharmaceuticals and Zymeworks shares are...
Benzinga Newsdesk
Reported Earlier, Jazz Pharmaceuticals Secure...
Benzinga Newsdesk
Monday, November 18, 2024
Baird Maintains Outperform on Jazz Pharmaceut...
Benzinga Newsdesk
Thursday, November 14, 2024
Neena M Patil Executes Sell Order: Offloads $456K In Jazz Pharmaceuticals Stock
Benzinga Insights
Friday, November 08, 2024
UK Parents Want National Health Service To Allow Cannabis For Children With Epilepsy
Nina Zdinjak
Thursday, November 07, 2024
TD Cowen Maintains Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Jazz Pharmaceuticals shares are trading highe...
Benzinga Newsdesk
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Wednesday, November 06, 2024
Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth?
Nicolás Jose Rodriguez
Jazz Pharmaceuticals Sees FY24 Adj EPS $19.50...
Benzinga Newsdesk
Jazz Pharmaceuticals Q3 2024 Adj EPS $6.61 Be...
Benzinga Newsdesk
Insider Decision: Bruce C Cozadd Offloads $110K Worth Of Jazz Pharmaceuticals Stock
Benzinga Insights
Thursday, October 31, 2024
Jazz Pharmaceuticals Presents New Data At Psy...
Benzinga Newsdesk
Avadel Pharmaceuticals Says US District Court...
Benzinga Newsdesk
Wednesday, October 23, 2024
In-Depth Examination Of 12 Analyst Recommendations For Jazz Pharmaceuticals
Benzinga Insights
RBC Capital Maintains Outperform on Jazz Phar...
Benzinga Newsdesk
Wednesday, October 16, 2024
Jazz Pharmaceuticals Unit Terminates Lease Ag...
Benzinga Newsdesk
Tuesday, October 15, 2024
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Vandana Singh
Jazz Pharmaceuticals Reports Results For Zepz...
Benzinga Newsdesk
Friday, October 04, 2024
Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts
Benzinga Insights
RBC Capital Maintains Outperform on Jazz Phar...
Benzinga Newsdesk
Tuesday, October 01, 2024
Is Jazz Pharmaceuticals Stock Undervalued Right Now?
Zacks
Thursday, September 19, 2024
FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms
Rolando García
Monday, September 16, 2024
Jazz Pharmaceuticals Announced Updated Data, ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Monday, September 09, 2024
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Jazz Pharmaceuticals Highlights Zanidatamab a...
Benzinga Newsdesk
Friday, September 06, 2024
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Zacks
Wednesday, September 04, 2024
Jazz Pharmaceuticals Launches $850M Senior No...
Benzinga Newsdesk
Tuesday, September 03, 2024
Jazz Intends To Offer $850M Of Exchangeable S...
Benzinga Newsdesk
Wednesday, August 28, 2024
Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
Vandana Singh
'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine
Nina Zdinjak
Friday, August 23, 2024
The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal
Nina Zdinjak
Thursday, August 22, 2024
Jazz Pharmaceuticals Provides Update On Canna...
Benzinga Newsdesk
Monday, August 19, 2024
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
